Analyst firms · H.C. Wainwright · VRCA

H.C. Wainwright VRCA price target and rating history

Verrica Pharmaceuticals Inc. (VRCA) · Health Care

H.C. Wainwright rates Verrica Pharmaceuticals Inc. (VRCA) Buy with a $12 price target, as of its latest action on May 26, 2026. It has published 3 rating actions on VRCA since September 2021, including 0 upgrades and 1 downgrade.

Current rating
Buy
Price target
$12
Median target, all firms
Too few
Actions on VRCA
3

H.C. Wainwright price target on VRCA

$20$16$1220222023202420252026
H.C. Wainwright price target on VRCA, each point a stated target, September 2021 to May 2026.

Every H.C. Wainwright rating on VRCA

How other firms rate VRCA

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Lake StreetBuy$9Aug 27, 2026
H.C. WainwrightBuy$12May 26, 2026

Questions about H.C. Wainwright and VRCA

What is H.C. Wainwright's price target for VRCA?
H.C. Wainwright's latest stated price target for Verrica Pharmaceuticals Inc. (VRCA) is $12, from its action on May 26, 2026.
What is H.C. Wainwright's rating on VRCA?
H.C. Wainwright rates VRCA Buy, a bullish rating, as of May 26, 2026.
When did H.C. Wainwright last change its view on VRCA?
On May 26, 2026, H.C. Wainwright resumes coverage at Buy, price target $12.

More VRCA rating histories

All H.C. Wainwright ratingsVRCA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.